News
Trial results for Pfizer and BioNTech’s COVID-19 vaccine for children released
Pfizer and BioNTech have announced updated phase 2/3 trial results for their COVID-19 vaccine for children aged six months to four years.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Pfizer and BioNTech have announced updated phase 2/3 trial results for their COVID-19 vaccine for children aged six months to four years.